Cargando…

Higher T cell immunoglobulin mucin-3 (Tim-3) expression in cervical cancer is associated with a satisfactory prognosis

BACKGROUND: Cervical cancer (CC), which has been increasing in incidence in recent years, is the fourth most common gynecological cancer in the world. Therapy targeting T cell immunoglobulin mucin-3 (Tim-3), known as the immune checkpoint, has been rapidly developing as oncotherapy for various carci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yaping, Zhao, Shujun, Zhang, Xinlu, Zhu, Hai, Ji, Xiaorong, Jiang, Yi, Meng, Jie, Shi, Hongyu, Gao, Xiang, Zhang, Xiaoan, Li, Hongyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797693/ https://www.ncbi.nlm.nih.gov/pubmed/35117637 http://dx.doi.org/10.21037/tcr.2020.02.41

Ejemplares similares

Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)
por: Homayouni, Vida, et al.
Publicado: (2016)

T Cell Immunoglobulin and Mucin Domain 3 (TIM-3) in Cutaneous Melanoma: A Narrative Review
por: Cazzato, Gerardo, et al.
Publicado: (2023)

T Cell Immunoglobulin Mucin Domain (TIM)-3 Promoter Activity in a Human Mast Cell Line
por: Kim, Jung Sik, et al.
Publicado: (2012)

Association of T-Cell Immunoglobulin and Mucin Domain-Containing Molecule 3 (Tim-3) Polymorphisms with Susceptibility and Disease Progression of HBV Infection
por: Liao, Jingyu, et al.
Publicado: (2014)

Regulation of Th1 T Cell Differentiation by Iron via Upregulation of T Cell Immunoglobulin and Mucin Containing Protein-3 (TIM-3)
por: Pfeifhofer-Obermair, Christa, et al.
Publicado: (2021)

Inhibition of T cell immunoglobulin and mucin-1 (TIM-1) protects against cerebral ischemia-reperfusion injury
por: Zheng, Yueying, et al.
Publicado: (2019)

CKMT1A is a novel potential prognostic biomarker in patients with endometrial cancer
por: Wang, Yaping, et al.
Publicado: (2022)

Correction to: Inhibition of T cell immunoglobulin and mucin-1 (TIM-1) protects against cerebral ischemia-reperfusion injury
por: Zheng, Yueying, et al.
Publicado: (2019)

Altered expression of T cell Immunoglobulin-Mucin (TIM) molecules in bronchoalveolar lavage CD4(+ )T cells in sarcoidosis
por: Idali, Farah, et al.
Publicado: (2009)

Altered expression of T cell Immunoglobulin-Mucin (Tim) molecules in peripheral blood mononuclear cells in aplastic anemia
por: Liu, Xin, et al.
Publicado: (2014)

T-Cell Immunoglobulin and Mucin Domain 1 (TIM-1) Is a Functional Entry Factor for Tick-Borne Encephalitis Virus
por: Zhang, Xiaowei, et al.
Publicado: (2022)

Knockdown of T Cell Immunoglobulin and Mucin 1 (Tim-1) Suppresses Glioma Progression Through Inhibition of the Cytokine-PI3K/AKT Pathway
por: Zhou, Peng, et al.
Publicado: (2020)

Structures of T Cell Immunoglobulin Mucin Receptors 1 and 2 Reveal Mechanisms for Regulation of Immune Responses by the TIM Receptor Family
por: Santiago, César, et al.
Publicado: (2007)

Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis
por: Migita, Kiyoshi, et al.
Publicado: (2020)

Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
por: Cao, Yang, et al.
Publicado: (2013)

C3–6 Laminoplasty for Cervical Spondylotic Myelopathy Maintains Satisfactory Long-Term Surgical Outcomes
por: Sakaura, Hironobu, et al.
Publicado: (2014)

Correction: Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
por: Cao, Yang, et al.
Publicado: (2016)

Expression changes of Tim-3 as one of supplementary indicators for monitoring prognosis of liver pathological changes in chronic HBV infection
por: Wu, Shanshan, et al.
Publicado: (2022)

Upregulation of Tim‐3 is associated with poor prognosis in acute myeloid leukemia
por: Wu, Zhengwei, et al.
Publicado: (2022)

Tim1 and Tim3 are not essential for experimental allergic asthma
por: Barlow, J L, et al.
Publicado: (2011)

Plastic spatula with narrow long tip provides higher satisfactory smears for Pap test
por: Kaur, Pervinder, et al.
Publicado: (2013)

Serum T Cell Immunoglobulin Mucin 3 Predicts Worse Prognosis in Hepatocellular Carcinoma Patients Undergoing Transcatheter Arterial Chemoembolization
por: Li, Jun, et al.
Publicado: (2022)

Immune regulation by Tim-3
por: Banerjee, Hridesh, et al.
Publicado: (2018)

Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus
por: Song, Li-jun, et al.
Publicado: (2015)

Galectin-9 contributes to the pathogenesis of atopic dermatitis via T cell immunoglobulin mucin-3
por: Su, Wenxing, et al.
Publicado: (2022)

Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy
por: Dama, Paola, et al.
Publicado: (2019)

T cell immunoglobulin and mucin domain-containing protein 3 is highly expressed in patients with acute decompensated heart failure and predicts mid-term prognosis
por: Meng, Xin, et al.
Publicado: (2022)

High Interleukin-37 (IL-37) Expression and Increased Mucin-Domain Containing-3 (TIM-3) on Peripheral T Cells in Patients with Rheumatoid Arthritis
por: Song, Lijun, et al.
Publicado: (2018)

A Satisfactory Financial Position
Publicado: (1916)

Are Our Dental Organizations Satisfactory?
Publicado: (1894)

Development and Characterization of a Nanobody against Human T-Cell Immunoglobulin and Mucin-3
por: Xia, Mingyuan, et al.
Publicado: (2022)

Effect of sex differences on prognosis of intravenous thrombolysis: data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
por: Zhou, Hongyu, et al.
Publicado: (2020)

PD‐1+ TIM‐3+ T cells in malignant ascites predict prognosis of gastrointestinal cancer
por: Nakano, Michitaka, et al.
Publicado: (2018)

Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3(+) CD8(+) T Cells and Survival in Diffuse Large B Cell Lymphoma
por: Zhang, Tingting, et al.
Publicado: (2020)

TIM-3 expression in breast cancer
por: Burugu, Samantha, et al.
Publicado: (2018)

Altered expression of Tim family molecules and an imbalanced ratio of Tim-3 to Tim-1 expression in patients with type 1 diabetes
por: Liu, Yikai, et al.
Publicado: (2022)

T-cell immunoglobulin mucin-3 expression in invasive ductal breast carcinoma: Clinicopathological correlations and association with tumor infiltration by cytotoxic lymphocytes
por: Zhang, Huan, et al.
Publicado: (2017)

TIM-Finder: A new method for identifying TIM-barrel proteins
por: Si, Jing-Na, et al.
Publicado: (2009)

T‐cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer
por: Liu, Jian‐Feng, et al.
Publicado: (2017)

SUV39H1-DNMT3A-mediated epigenetic regulation of Tim-3 and galectin-9 in the cervical cancer
por: Zhang, Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3utmmhpji4rc0puni44l6664hl